What is BlueSemi?
BlueSemi operates at the intersection of semiconductor technology and preventative healthcare. By developing non-invasive devices capable of tracking six critical health vitals, the company addresses a significant gap in the consumer and clinical health monitoring market. Unlike traditional diagnostic tools that often require invasive procedures or bulky equipment, BlueSemi's technology emphasizes portability, accuracy, and seamless data integration. This positioning allows the company to serve a diverse range of stakeholders, from individual consumers seeking proactive health management to enterprise clients looking for integrated wellness solutions. Their market position is further strengthened by the strategic alignment with major technology conglomerates, which provides both technical validation and potential pathways for large-scale distribution.
How much funding has BlueSemi raised?
BlueSemi has raised a total of $69.3M across 2 funding rounds:
Angel/Seed
$300K
Debt
$69M
Angel/Seed (2020): $300K with participation from Samsung Electronics, KLA, Google, and Microsoft
Debt (2021): $69M led by Global Emerging Markets
Key Investors in BlueSemi
Samsung Electronics
A global technology leader specializing in consumer electronics, semiconductor technologies, and integrated digital solutions that enhance healthcare and everyday living.
KLA
A premier semiconductor equipment company focused on advanced process control and metrology systems essential for high-precision chip manufacturing.
A global technology giant dedicated to organizing information and providing platforms that support innovation across mobile, cloud, and health-related digital services.
What's next for BlueSemi?
With the recent infusion of capital, BlueSemi is poised to transition into a phase of aggressive market penetration and product refinement. The strategic focus will likely center on scaling manufacturing capabilities to meet anticipated demand for its non-invasive vital monitoring hardware. Furthermore, the company is expected to deepen its integration with existing digital health platforms, enhancing the utility of the data collected by its devices. As BlueSemi continues to mature, the focus will shift toward securing regulatory approvals in key international markets and establishing long-term partnerships with healthcare providers and insurance entities. This strategic roadmap is designed to solidify the company's role as a foundational player in the future of remote patient monitoring and personalized health analytics.
See full BlueSemi company page
